The effect of radiotherapy, and radiotherapy combined with bisphosphonates or RANK ligand inhibitors on bone quality in bone metastases. A systematic review

Author(s):
Groenen, K.H.J.; Pouw, M.H.; Hannink, G.; Hosman, A.J.F.; Linden, Y.M. van der; Verdonschot, N.; Tanck, E.
Published
2016
Publication type
Article / Letter to editor
RadiotherapyBisphosphonateRANKL inhibitorBone metastasisBone qualityPathological fracture
Date issued
2016-05-31
Language
English
Is part of
Radiotherapy and Oncology (2016), Vol. 119, no. 2, p. 194-201
hdl
1887/113072
doi
10.1016/j.radonc.2016.03.001